The World Health Organization (WHO) has introduced a set of recommendations designed to embed mental health considerations into every corner of government policymaking.
The trajectory of a human’s life course is by no means determined at birth. Nevertheless, the circumstances a child is born into and events taking place during the early childhood, or even gestation, shape life-course trajectories.
Hernando Lopez-Bertoni, explores the new wave of molecular cancer therapeutics and states the case for learning the mechanisms as a pro, so one can target them as an artist.
Prof Dr Susanne M Bailer, Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, explains the possibilities of an oncolytic virus platform technology.
Dr Stephen Barnhill MD, CEO of Apollon Formularies Plc, examines medical cannabis and the future of cancer treatments across the UK and the European healthcare sectors.
Ivan Toplak, Professor from the University of Ljubljana, Veterinary Faculty, reveals what we know about honeybee viral strains and transmission between honeybee colonies.
Pascale V Guillot, Associate Professor at University College London, investigates the possibility of exosome therapy for those living with brittle bone disease.
Clarifying what kind of support is provided by universities in Scotland, as ‘Corporate Parents’, to children and young people who have experienced social care in the UK in comparison with Japan.
Nicola Hemmings, workplace scientist at Koa Health, and Dr Claire Vowell, lead psychologist, discuss how mental health conditions exist across a continuum and address what organisations can do to better support those who do not have a mental health diagnosis.
Recent years have seen an increase in techniques developed for spatial transcriptomics, enabling gene expression patterns to be uncovered within intact, three-dimensional tissues.
